Ductal Lavage in Non-lactating Female Women With Mastitis
NCT02794688 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32
Last updated 2019-08-22
Summary
RATIONALE and PURPOSE: For non-lactational mastitis patients pathologically diagnosis of idiopathic granulomatous mastitis (IGM) or periductal mastitis (PD), the investigators hypothesized that ductal lavage is able to relieve the symptoms and achieve complete response, with shorter recovery time than oral intake of antibiotics or corticosteroids treatments. This single arm, observational, case series, pilot study is going to evaluate the effectiveness of ductal lavage in patients with non-lactational IGM or PD.
Conditions
- Mastitis
Interventions
- PROCEDURE
-
Ductal lavage therapy
1. Patient lies in supine position, with routine sterilizing and draping procedure. 2. Local anesthesia with 2ml lidocaine (1%) around the nipple. 3. Identification of 4-5 openings of the lactiferous ducts from the nipple. 4. Insertion of all infusion cannula (21-23G ) into the identified openings of the lactiferous ducts. 5. Start the infusion pump with 15ml irrigation solution (2% Lidocaine 5ml, Triamcinolone acetonide 40mg,0.9% saline 10ml and ceftriaxone 1.0g). If the patients had elevated white blood cell count and fever (\>38 celsius degree), oral intake or infusion of antibiotics were allowed, when necessary. 6. The patient returns to the clinic the next day, with the irrigation solution staying in the lactiferous ducts overnight, and receives breast massage. 7. Repeat step 1-6 every other day for 2 weeks. 8. Fine needle aspiration is allowed. Oral intake of corticosteroids, excisional drainage or surgery are not allowed.
Sponsors & Collaborators
-
Guangzhou Jie Jian Instrument Co,Ltd
collaborator UNKNOWN -
China Anti-aging Promoting Association
collaborator OTHER -
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
lead OTHER
Principal Investigators
-
Shunrong Li, M.D. · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
-
Erwei Song, M.D. · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-08-31
- Primary Completion
- 2018-07-31
- Completion
- 2019-06-05
Countries
- China
Study Locations
More Related Trials
-
Intra-operative Radiotherapy For Women With Ductal Carcinoma in Situ Breast Cancer
NCT02389673 ·Status: RECRUITING ·Phase: NA
-
Ultrasound Guided Percutaneous Microwave Ablation for Breast Lesions
NCT02860104 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Idiopathic Granulomatous Mastitis Combination Therapy
NCT05361629 ·Status: UNKNOWN ·Phase: NA
-
Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery
NCT06297265 ·Status: RECRUITING ·Phase: NA
-
Drain Removal on Postoperative Safety and Patient Satisfaction in R-E-NSM With Prepectoral DIBR
NCT07237828 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Different Surgical Approaches of Granulomatous Mastitis
NCT06712524 ·Status: RECRUITING ·Phase: NA
-
Microwave Ablation in the Treatment of Early-stage Unifocal Invasive Breast Cancer
NCT06288620 ·Status: RECRUITING ·Phase: NA
-
Somatic Acupressure for Symptom Cluster Management in Breast Cancer Survivors
NCT06412107 ·Status: COMPLETED ·Phase: NA
-
Comparison of Microwave Ablation With Cryoablation for Breast Tumor
NCT03286413 ·Status: UNKNOWN ·Phase: NA
-
Pulsed Lavage in Implant-Based Breast Reconstruction
NCT05585710 ·Status: RECRUITING ·Phase: NA
-
Assessment of Muscle Strength and Volume Changes in Patients With Breast Cancer- Related Lymphedema
NCT03945838 ·Status: COMPLETED
-
Could Intralesional Steroid be the Novel Treatment for Granulomatous Mastitis?
NCT04596046 ·Status: COMPLETED ·Phase: NA
-
Granulomatous Mastitis Current Approach and Treatment
NCT02667132 ·Status: COMPLETED
-
Surgical Intervention for Refractory Granulomatous Lobular Mastitis
NCT04637711 ·Status: RECRUITING ·Phase: NA
-
Study of the Change of Breast Cancer Patients' Upper Limb Lymphatic Drainage Pathway After Operation
NCT02691624 ·Status: UNKNOWN
-
Omission of ALND in Breast Cancer Patients With Axillary pCR
NCT05939830 ·Status: RECRUITING ·Phase: NA
-
Evaluation for the Effectiveness and Safety of Cryo-ablation in the Treatment of Early Invasive Breast Cancer
NCT04334785 ·Status: UNKNOWN ·Phase: NA
-
Comparing Level 1 Compression Sleeves With Routine Care in Preventing Breast Cancer-related Arm Lymphedema
NCT06095323 ·Status: RECRUITING ·Phase: NA
-
Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients
NCT04320979 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
NCT06144164 ·Status: RECRUITING ·Phase: PHASE3
-
Immediate Axillary Plasty With a Pedicled Muscle Flap for Breast Cancer Related Lymphedema Prevention
NCT02318615 ·Status: UNKNOWN ·Phase: NA
-
Non-Invasive Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy Techniques (MRS) for Assessing Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
NCT00490503 ·Status: COMPLETED
-
A Prospective Validation Cohort Study of a Prediction System on nSLN Metastasis in Early Breast Cancer
NCT03280134 ·Status: UNKNOWN ·Phase: NA
-
Supraclavicular Lymph Node Dissection for Ipsilateral Supraclavicular Lymph Node Metastatic Breast Cancer
NCT06383663 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer
NCT00723294 ·Status: UNKNOWN ·Phase: PHASE2